Business Description
Hemagen Diagnostics Inc
NAICS : 325412
SIC : 2834
ISIN : US4235011057
Description
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.86 | |||||
9-Day RSI | 27.27 | |||||
14-Day RSI | 34.82 | |||||
3-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HMGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hemagen Diagnostics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.042 | ||
| EPS (TTM) ($) | -0.06 | ||
| Beta | -60.4856 | ||
| 3-Year Sharpe Ratio | 0.63 | ||
| 3-Year Sortino Ratio | 4.71 | ||
| Volatility % | 779.92 | ||
| 14-Day RSI | 34.82 | ||
| 14-Day ATR ($) | 0.000024 | ||
| 20-Day SMA ($) | 0.0002 | ||
| 12-1 Month Momentum % | 100 | ||
| 52-Week Range ($) | 0.0001 - 0.1251 | ||
| Shares Outstanding (Mil) | 15.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hemagen Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hemagen Diagnostics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hemagen Diagnostics Inc Frequently Asked Questions
What is Hemagen Diagnostics Inc(HMGN)'s stock price today?
The current price of HMGN is $0.00. The 52 week high of HMGN is $0.13 and 52 week low is $0.00.
When is next earnings date of Hemagen Diagnostics Inc(HMGN)?
The next earnings date of Hemagen Diagnostics Inc(HMGN) is .
Does Hemagen Diagnostics Inc(HMGN) pay dividends? If so, how much?
Hemagen Diagnostics Inc(HMGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hemagen Diagnostics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers